Pfizer Inc. (PFE)
Analysis of Inventory
Accounting Policy on Inventory
Pfizer carries inventories at the lower of cost or net realizable value. The cost of finished goods, work in process and raw materials is determined using average actual cost. Pfizer regularly reviews the inventories for impairment and reserves are established when necessary.
Source: 10-K (filing date: 2019-02-28).
Pfizer Inc., balance sheet: inventory
US$ in millions
|Dec 31, 2018||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014|
|Work in process|
|Raw materials and supplies|
|Inventories||Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.||Pfizer Inc.’s inventories increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.|